Marcos J P Renni*
Clinical Research Division - INCA - National Institute of Cancer, Brazil
*Corresponding Author: Marcos J P Renni, Clinical Research Division - INCA - National Institute of Cancer, Brazil.
Received: October 26, 2022; Published: November 01, 2022
Cancer-associated venous thromboembolism is a common and life-threatening condition in patients with cancer. These patients have four to seven times more chance to develop VTE than patients without cancer. The factors responsible for the increased incidence of cancer associated VTE basically include the type of cancer and the ongoing antineoplastic treatment. The etiology of dysregulated hemostasis in cancer is multifactorial and has been associated with disease extent, tumor biology, local and systemic inflammation, cancer therapy, and patient-related factors.
Citation: Marcos J P Renni. “Challenges of Anticoagulation in Thrombosis and Cancer - Cardiooncology View". Acta Scientific Cardiovascular System 1.7 (2022): 01.
Copyright: © 2022 Marcos J P Renni. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Access by
Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com
ff
